MedTrace Logo

Propranolol for Treatment of Cocaine Addiction - 2

NCT00000197 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2017-01-12

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and efficacy of propanolol in the early treatment of cocaine dependence.

Conditions

  • Cocaine-Related Disorders

Interventions

DRUG

Propranolol

Sponsors & Collaborators

Principal Investigators

  • Kyle Kampman, M.D. · University of Pennsylvania

Study Design

Purpose
TREATMENT

Eligibility

Min Age
25 Years
Max Age
49 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1987-01-31
Primary Completion
2002-01-31
Completion
2002-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000197 on ClinicalTrials.gov